Welcome to the official website of the Ethypharm Group. This website is regulated by the Code of Best Practices of the International Federation of Pharmaceutical Manufacturers. Some information on this site may not be in conformity with French regulations on advertising. By continuing your navigation, you accept this website's use of cookies.

News & Press releases

Check here for our latest news, press releases, and publications.

NEWS

Ethypharm was honoured receiving the gold award in the category of “Best Management Team & MBO”

At the 7th edition of the “Private Equity Exchange Awards”, Ethypharm was honored receiving the Gold Award in the Category of “Best Management Team & MBO”. Congratulations to the teams involved. We are Ethypharm!

Kindness Day 2016

At Ethypharm we celebrated the International Kindness Day under the theme “Building Team Spirit”. At Ethypharm we promote a work culture that prioritizes development of talents and wellbeing. We are Ethypharm!

Visit our page on LinkedIn

The new website of Ethypharm UK is online

The new website of our subsidiary Ethypharm UK is online! We invite you to discover Ethypharm UK!

Discover Etypharm UK

PAI Partners is the new shareholder of Ethypharm

The 21st of July, PAI Partners became officially the new shareholder of Ethypharm.

Learn more

PRESS RELEASES

Michael Harris becomes Ethypharm’s Chief Operating Officer

Ethypharm, a European specialty pharmaceutical company, announces the appointment of Michael Harris as Chief Operating Officer of the Ethypharm Group.

Learn more

Ethypharm and Camurus sign agreement for distribution of episil® in France

Camurus AB and Ethypharm announced today that they have entered into an agreement under which Ethypharm has obtained exclusive distribution rights for episil® oral liquid in France. Based on a patented technology, episil® is an innovative treatment for the management and relief of oral mucositis pain, a common treatment-limiting side effect of cancer therapies.

Learn more

Ethypharm acquires Martindale Pharma in the UK

Ethypharm is pleased to announce today that it has signed a definitive agreement to acquire Martindale Pharma.

Learn more

Ethypharm appoints Andy Farrant as Managing Director of DB Ashbourne Ltd.

Ethypharm, a leading company in the development and manufacture of innovative medicines for pain and addiction and complex generics, is pleased to announce the appointment of Andy Farrant to the position of Managing Director of DB Ashbourne Ltd., (DBA) the UK based company Ethypharm has recently acquired.

Learn more

By clicking on this link, you agree to leave our website.
Are you sure?
NO     YES